Purpose: Microangiopathic hemolytic anemia (MAHA) is a microvascular hypercoagulable state characterized by Coombs-negative fragmentation hemolysis of red blood cells associated with thrombocytopenia and a propensity for bleeding. Cancer-related MAHA is a recognized clinical entity that portends a poor prognosis as compared to patients without MAHA. Here, we report a patient with metastatic signet cell adenocarcinoma (SCA) of the sigmoid colon complicated by MAHA and disseminated intravascular coagulation (DIC) after primary resection for recurrent tumor bleeding. A 59-year-old man presented with persistent anorexia and hematochezia. Computed tomography revealed a 6-cm mass in the sigmoid colon with metastatic disease to the liver. Colonoscopy revealed a mass 23 cm into the sigmoid. Biopsies showed carcinoma with signet-ring features. Liver biopsy confirmed metastatic adenocarcinoma. Systemic chemotherapy was not felt to be appropriate at the time of diagnosis, given the risk of poor wound healing with chemotherapy, thrombocytopenia, and impaired liver function. A sigmoid resection was performed with seven out of seven lymph nodes positive for metastatic disease. Postoperatively, the patient developed an extraperitoneal hematoma, requiring intraoperative drainage. In addition to refractory anemia, the patient developed several laboratory derangements, including low fibrinogen levels (142 mg/dL) and thrombocytopenia, (platelet 30K/μL) despite repeated transfusions, hyperbilirubinemia (T. bili 48.2 mg/dL), elevated alkaline phosphatase (613 unit/L), fibrin split products (>20 mg/dL), and marked coagulopathy. The patient was subsequently transferred to a tertiary care institution, where the diagnosis of MAHA was made after peripheral smear evaluation confirmed the presence of schistocytosis. Despite aggressive transfusion support, the patient remained clinically unstable, preventing initiation of systemic chemotherapy. Given his continued deterioration, a more palliative approach was undertaken. MAHA is exceedingly rare in patients with SCA. However, our case and prior reports suggest that patients with advanced disease who undergo surgical manipulation before chemotherapy may be more likely to develop MAHA and DIC. This could be a result of disruption of abnormal blood vessels supplying the tumor and subsequent release of tumor-induced metabolites like mucin, triggering alterations in hemostasis. Therefore, we propose that neoadjuvant chemotherapy be considered prior to surgical resection, especially in patients with advanced disease at the time of diagnosis; however, a larger number of patients with this phenomenon would be required to draw clear clinical recommendations.
Read full abstract